FDA Guidance on Reducing WNV Transmission from Living Donors of Human Cells and Tissues

Summary

The Food and Drug Administration (FDA) has released a guidance document recommending the use of nucleic acid tests to screen living donors of human cells, tissues, and products for West Nile Virus (WNV). This guidance finalizes a draft from 2015 and supplements existing donor screening recommendations.